Litcius/Paper detail

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

Fenne L. Komdeur, Amrita Singh, Stephanie van de Wall, J. J. M. Meulenberg, Annemarie Boerma, Baukje Nynke Hoogeboom, Sterre T. Paijens, César Oyarce, Marco de Bruyn, Ed Schuuring, Joke Regts, R.B. Marra, Naomi Werner, J. J. A. Sluis, Ate G.J. van der Zee, Jan Wilschut, Derk P. Allersma, Coba J. van Zanten, Jos G. W. Kosterink, Annelies Jorritsma‐Smit, Refika Yigit, Hans W. Nijman, Toos Daemen

2020Molecular Therapy82 citationsDOIOpen Access PDF

Topics & Concepts

RepliconVirologyCervical cancerCancer researchRNAClinical trialBiologyCancerMedicineOncologyGeneGeneticsBioinformaticsGenomeVirus-based gene therapy researchAnimal Virus Infections StudiesHepatitis B Virus Studies